COG — Cambridge Cognition Holdings Share News
0.000.00%
- £18.56m
- £17.90m
- £13.52m
REG - Cambridge Cognition - Price Monitoring Extension
AnnouncementREG - Cambridge Cognition - Second Price Monitoring Extn
AnnouncementREG - Cambridge Cognition - £1 million contract for pivotal autoimmune trial
AnnouncementREG - Cambridge Cognition - Appointment of Nominated Adviser and Joint Broker
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - £2.1 million contract
AnnouncementREG - Cambridge Cognition - Trading Update
AnnouncementREG - Cambridge Cognition - New Major Pharma Client for Schizophrenia Trials
AnnouncementREG - Cambridge Cognition - Electronic Clinical Outcomes Assessment Contract
AnnouncementREG - Cambridge Cognition - £1.0m Schizophrenia clinical trial contract
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Grant of Options
AnnouncementREG - Cambridge Cognition - Directorate Change
AnnouncementREG - Cambridge Cognition - Contract for pivotal schizophrenia clinical trial
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Interim Results
AnnouncementREG - Cambridge Cognition - Trading Update and Notice of Results
AnnouncementREG - Cambridge Cognition - Second Price Monitoring Extn
AnnouncementREG - Cambridge Cognition - Price Monitoring Extension
Announcement